insights_auto
Bakit tumaas ang NOV 2.76%?
Tingnan ang Higit pang Detalyechevron_right
NOV:ETR
Novo Nordisk A/S
€35.32
arrow_upward
+2.76%(+0.95) 1D
Okt 15, 5:35:38 PM GMT+2 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa NOV...
Buksan
€34.26
Mataas
€35.36
Mababa
€34.19
Mkt. cap
133.83B
Avg. na dami
178.28K
Dami
220.59K
Mataas nang 52-wk
€54.87
Mababa nang 52-wk
€30.24
Bilang ng mga empleyado
67K
Buksan
€34.26
Mataas
€35.36
Mababa
€34.19
Mkt. cap
133.83B
Avg. na dami
178.28K
Dami
220.59K
Mataas nang 52-wk
€54.87
Mababa nang 52-wk
€30.24
Bilang ng mga empleyado
67K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
TradingKey
·
6 oras ang nakalipas
Novo Nordisk A/S Stock (NVO) Moved Up by 3.38% on Oct 15: What Investors Need To Know
Traders Union
·
11 oras ang nakalipas
Why is Novo Nordisk stock up 3.2% today?
ad-hoc-news.de
·
16 oras ang nakalipas
Novo Nordisk stock gains 1.12 percent ahead of November 4 results
Traders Union
·
17 oras ang nakalipas
Novo Nordisk stock consolidates amid seller pressure near $38.39 resistance
Profile
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark, and it became the highest valued company in Europe. Wikipedia
Tungkol sa Novo Nordisk A/S
CEOMaziar Mike Doustdar
Mga Empleyado66.7K
Itinatag1923
HeadquartersBagsværd, Capital Region of Denmark, Denmark
Sektor-
Websitenovonordisk.com